Felipe Couñago, National Clinical Director at GenesisCare, shared a post on LinkedIn:
“Exciting news!
I am honored to serve as Guest Editor for the Cancers (MDPI) Special Issue:
‘Perioperative and Adjuvant Immunotherapy in Lung Cancer: New Strategies, Biomarkers, Patient Selection and Toxicity Management’
We warmly invite you to submit your original research, reviews, or communications addressing:
- New strategies in perioperative/adjuvant immunotherapy
- Biomarkers for patient selection and toxicity prediction
- Mechanisms of resistance and innovative combinations
- Integration with surgery, radiotherapy, and other therapies
- Real-world evidence and AI applications
Submission deadline: July 31, 2026
Open access in Cancers (MDPI)
A big thank you to my fellow Guest Editors
- Dr. Xabier Mielgo Rubio
- Dr. Juan Carlos Trujillo Reyes
Together, we look forward to building a high-quality collection that will shape the future of lung cancer care.
Check out the Special Issue and submission details.”
Read more posts featuring Felipe Couñago, on OncoDaily.